nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosphenytoin—CYP2B6—Irinotecan—colon cancer	0.118	0.164	CbGbCtD
Fosphenytoin—ALB—Irinotecan—colon cancer	0.116	0.161	CbGbCtD
Fosphenytoin—ALB—Fluorouracil—colon cancer	0.111	0.154	CbGbCtD
Fosphenytoin—CYP2C9—Capecitabine—colon cancer	0.101	0.14	CbGbCtD
Fosphenytoin—CYP2C8—Fluorouracil—colon cancer	0.0861	0.119	CbGbCtD
Fosphenytoin—ALB—Methotrexate—colon cancer	0.0614	0.085	CbGbCtD
Fosphenytoin—CYP2C9—Fluorouracil—colon cancer	0.06	0.0831	CbGbCtD
Fosphenytoin—CYP3A4—Irinotecan—colon cancer	0.0364	0.0503	CbGbCtD
Fosphenytoin—CYP3A4—Vincristine—colon cancer	0.0318	0.044	CbGbCtD
Fosphenytoin—Conjunctivitis—Fluorouracil—colon cancer	0.000807	0.00291	CcSEcCtD
Fosphenytoin—Amnesia—Capecitabine—colon cancer	0.000802	0.00289	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Vincristine—colon cancer	0.000795	0.00287	CcSEcCtD
Fosphenytoin—Bradycardia—Irinotecan—colon cancer	0.000793	0.00286	CcSEcCtD
Fosphenytoin—Epistaxis—Fluorouracil—colon cancer	0.000783	0.00283	CcSEcCtD
Fosphenytoin—Rhinitis—Irinotecan—colon cancer	0.00078	0.00282	CcSEcCtD
Fosphenytoin—Sinusitis—Fluorouracil—colon cancer	0.000779	0.00281	CcSEcCtD
Fosphenytoin—Vaginal inflammation—Methotrexate—colon cancer	0.000772	0.00279	CcSEcCtD
Fosphenytoin—Pulmonary embolism—Methotrexate—colon cancer	0.000772	0.00279	CcSEcCtD
Fosphenytoin—Diplopia—Capecitabine—colon cancer	0.000753	0.00272	CcSEcCtD
Fosphenytoin—Osteoarthritis—Capecitabine—colon cancer	0.000753	0.00272	CcSEcCtD
Fosphenytoin—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.000753	0.00272	CcSEcCtD
Fosphenytoin—Rhinitis—Fluorouracil—colon cancer	0.000748	0.0027	CcSEcCtD
Fosphenytoin—Depressed level of consciousness—Methotrexate—colon cancer	0.000746	0.00269	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Fluorouracil—colon cancer	0.000742	0.00268	CcSEcCtD
Fosphenytoin—Migraine—Capecitabine—colon cancer	0.000741	0.00267	CcSEcCtD
Fosphenytoin—Pharyngitis—Fluorouracil—colon cancer	0.00074	0.00267	CcSEcCtD
Fosphenytoin—Vaginal infection—Methotrexate—colon cancer	0.000729	0.00263	CcSEcCtD
Fosphenytoin—Face oedema—Capecitabine—colon cancer	0.000727	0.00262	CcSEcCtD
Fosphenytoin—Cardiac arrest—Capecitabine—colon cancer	0.000716	0.00258	CcSEcCtD
Fosphenytoin—Urinary retention—Capecitabine—colon cancer	0.000716	0.00258	CcSEcCtD
Fosphenytoin—Mood swings—Capecitabine—colon cancer	0.000713	0.00257	CcSEcCtD
Fosphenytoin—Ataxia—Capecitabine—colon cancer	0.000708	0.00256	CcSEcCtD
Fosphenytoin—Coma—Methotrexate—colon cancer	0.000706	0.00255	CcSEcCtD
Fosphenytoin—Dehydration—Capecitabine—colon cancer	0.0007	0.00253	CcSEcCtD
Fosphenytoin—Chills—Irinotecan—colon cancer	0.000699	0.00252	CcSEcCtD
Fosphenytoin—Urine output increased—Methotrexate—colon cancer	0.000698	0.00252	CcSEcCtD
Fosphenytoin—Ecchymosis—Methotrexate—colon cancer	0.000698	0.00252	CcSEcCtD
Fosphenytoin—Liver function test abnormal—Capecitabine—colon cancer	0.000695	0.00251	CcSEcCtD
Fosphenytoin—Orthostatic hypotension—Capecitabine—colon cancer	0.000688	0.00248	CcSEcCtD
Fosphenytoin—Hypokalaemia—Capecitabine—colon cancer	0.000685	0.00247	CcSEcCtD
Fosphenytoin—Back pain—Vincristine—colon cancer	0.000673	0.00243	CcSEcCtD
Fosphenytoin—Sepsis—Methotrexate—colon cancer	0.00067	0.00242	CcSEcCtD
Fosphenytoin—Flatulence—Irinotecan—colon cancer	0.000668	0.00241	CcSEcCtD
Fosphenytoin—Gastritis—Capecitabine—colon cancer	0.000667	0.00241	CcSEcCtD
Fosphenytoin—Muscular weakness—Capecitabine—colon cancer	0.000664	0.0024	CcSEcCtD
Fosphenytoin—Lymphadenopathy—Methotrexate—colon cancer	0.000657	0.00237	CcSEcCtD
Fosphenytoin—Back pain—Irinotecan—colon cancer	0.000656	0.00237	CcSEcCtD
Fosphenytoin—Muscle spasms—Irinotecan—colon cancer	0.000652	0.00235	CcSEcCtD
Fosphenytoin—Asthma—Capecitabine—colon cancer	0.000651	0.00235	CcSEcCtD
Fosphenytoin—Influenza—Capecitabine—colon cancer	0.000651	0.00235	CcSEcCtD
Fosphenytoin—Dysphagia—Capecitabine—colon cancer	0.000651	0.00235	CcSEcCtD
Fosphenytoin—Thrombophlebitis—Methotrexate—colon cancer	0.000648	0.00234	CcSEcCtD
Fosphenytoin—Anaemia—Vincristine—colon cancer	0.000643	0.00232	CcSEcCtD
Fosphenytoin—Agitation—Vincristine—colon cancer	0.000639	0.00231	CcSEcCtD
Fosphenytoin—Polyuria—Methotrexate—colon cancer	0.000639	0.0023	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Irinotecan—colon cancer	0.000629	0.00227	CcSEcCtD
Fosphenytoin—Anaemia—Irinotecan—colon cancer	0.000626	0.00226	CcSEcCtD
Fosphenytoin—Bronchitis—Capecitabine—colon cancer	0.000626	0.00226	CcSEcCtD
Fosphenytoin—Vertigo—Vincristine—colon cancer	0.000625	0.00226	CcSEcCtD
Fosphenytoin—Leukopenia—Vincristine—colon cancer	0.000623	0.00225	CcSEcCtD
Fosphenytoin—Malaise—Irinotecan—colon cancer	0.000611	0.00221	CcSEcCtD
Fosphenytoin—Vertigo—Irinotecan—colon cancer	0.000609	0.0022	CcSEcCtD
Fosphenytoin—Dysuria—Capecitabine—colon cancer	0.000609	0.0022	CcSEcCtD
Fosphenytoin—Syncope—Irinotecan—colon cancer	0.000608	0.00219	CcSEcCtD
Fosphenytoin—Leukopenia—Irinotecan—colon cancer	0.000607	0.00219	CcSEcCtD
Fosphenytoin—Convulsion—Vincristine—colon cancer	0.000603	0.00218	CcSEcCtD
Fosphenytoin—Hypertension—Vincristine—colon cancer	0.000601	0.00217	CcSEcCtD
Fosphenytoin—Anaemia—Fluorouracil—colon cancer	0.0006	0.00216	CcSEcCtD
Fosphenytoin—Loss of consciousness—Irinotecan—colon cancer	0.000596	0.00215	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Capecitabine—colon cancer	0.000594	0.00214	CcSEcCtD
Fosphenytoin—Myalgia—Vincristine—colon cancer	0.000592	0.00214	CcSEcCtD
Fosphenytoin—Cough—Irinotecan—colon cancer	0.000591	0.00213	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Capecitabine—colon cancer	0.000587	0.00212	CcSEcCtD
Fosphenytoin—Hypertension—Irinotecan—colon cancer	0.000585	0.00211	CcSEcCtD
Fosphenytoin—Pneumonia—Capecitabine—colon cancer	0.000584	0.00211	CcSEcCtD
Fosphenytoin—Leukopenia—Fluorouracil—colon cancer	0.000581	0.0021	CcSEcCtD
Fosphenytoin—Anaphylactoid reaction—Methotrexate—colon cancer	0.000579	0.00209	CcSEcCtD
Fosphenytoin—Renal failure—Capecitabine—colon cancer	0.000571	0.00206	CcSEcCtD
Fosphenytoin—Discomfort—Irinotecan—colon cancer	0.00057	0.00206	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Vincristine—colon cancer	0.000568	0.00205	CcSEcCtD
Fosphenytoin—Infection—Vincristine—colon cancer	0.000564	0.00204	CcSEcCtD
Fosphenytoin—Conjunctivitis—Capecitabine—colon cancer	0.000564	0.00204	CcSEcCtD
Fosphenytoin—Convulsion—Fluorouracil—colon cancer	0.000562	0.00203	CcSEcCtD
Fosphenytoin—Osteoarthritis—Methotrexate—colon cancer	0.000561	0.00202	CcSEcCtD
Fosphenytoin—Confusional state—Irinotecan—colon cancer	0.000558	0.00201	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Vincristine—colon cancer	0.000556	0.00201	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Irinotecan—colon cancer	0.000553	0.002	CcSEcCtD
Fosphenytoin—Myalgia—Fluorouracil—colon cancer	0.000553	0.00199	CcSEcCtD
Fosphenytoin—Infection—Irinotecan—colon cancer	0.000549	0.00198	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Vincristine—colon cancer	0.000549	0.00198	CcSEcCtD
Fosphenytoin—Epistaxis—Capecitabine—colon cancer	0.000547	0.00198	CcSEcCtD
Fosphenytoin—Discomfort—Fluorouracil—colon cancer	0.000546	0.00197	CcSEcCtD
Fosphenytoin—Shock—Irinotecan—colon cancer	0.000544	0.00196	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Irinotecan—colon cancer	0.000542	0.00195	CcSEcCtD
Fosphenytoin—Anorexia—Vincristine—colon cancer	0.000541	0.00195	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Irinotecan—colon cancer	0.000535	0.00193	CcSEcCtD
Fosphenytoin—Confusional state—Fluorouracil—colon cancer	0.000534	0.00193	CcSEcCtD
Fosphenytoin—Mood swings—Methotrexate—colon cancer	0.000531	0.00192	CcSEcCtD
Fosphenytoin—Hypotension—Vincristine—colon cancer	0.000531	0.00191	CcSEcCtD
Fosphenytoin—Bradycardia—Capecitabine—colon cancer	0.00053	0.00191	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Fluorouracil—colon cancer	0.00053	0.00191	CcSEcCtD
Fosphenytoin—Anorexia—Irinotecan—colon cancer	0.000527	0.0019	CcSEcCtD
Fosphenytoin—Ataxia—Methotrexate—colon cancer	0.000527	0.0019	CcSEcCtD
Fosphenytoin—Infection—Fluorouracil—colon cancer	0.000526	0.0019	CcSEcCtD
Fosphenytoin—Rhinitis—Capecitabine—colon cancer	0.000522	0.00188	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Fluorouracil—colon cancer	0.000519	0.00187	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Capecitabine—colon cancer	0.000518	0.00187	CcSEcCtD
Fosphenytoin—Liver function test abnormal—Methotrexate—colon cancer	0.000518	0.00187	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Vincristine—colon cancer	0.000517	0.00187	CcSEcCtD
Fosphenytoin—Pharyngitis—Capecitabine—colon cancer	0.000517	0.00187	CcSEcCtD
Fosphenytoin—Tachycardia—Fluorouracil—colon cancer	0.000517	0.00187	CcSEcCtD
Fosphenytoin—Hypotension—Irinotecan—colon cancer	0.000517	0.00186	CcSEcCtD
Fosphenytoin—Insomnia—Vincristine—colon cancer	0.000514	0.00185	CcSEcCtD
Fosphenytoin—Paraesthesia—Vincristine—colon cancer	0.00051	0.00184	CcSEcCtD
Fosphenytoin—Anorexia—Fluorouracil—colon cancer	0.000505	0.00182	CcSEcCtD
Fosphenytoin—Insomnia—Irinotecan—colon cancer	0.0005	0.00181	CcSEcCtD
Fosphenytoin—Paraesthesia—Irinotecan—colon cancer	0.000497	0.00179	CcSEcCtD
Fosphenytoin—Hypotension—Fluorouracil—colon cancer	0.000495	0.00179	CcSEcCtD
Fosphenytoin—Decreased appetite—Vincristine—colon cancer	0.000494	0.00178	CcSEcCtD
Fosphenytoin—Dyspnoea—Irinotecan—colon cancer	0.000493	0.00178	CcSEcCtD
Fosphenytoin—Somnolence—Irinotecan—colon cancer	0.000492	0.00177	CcSEcCtD
Fosphenytoin—Dyspepsia—Irinotecan—colon cancer	0.000487	0.00176	CcSEcCtD
Fosphenytoin—Tinnitus—Capecitabine—colon cancer	0.000486	0.00175	CcSEcCtD
Fosphenytoin—Constipation—Vincristine—colon cancer	0.000486	0.00175	CcSEcCtD
Fosphenytoin—Asthma—Methotrexate—colon cancer	0.000485	0.00175	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000483	0.00174	CcSEcCtD
Fosphenytoin—Decreased appetite—Irinotecan—colon cancer	0.000481	0.00173	CcSEcCtD
Fosphenytoin—Insomnia—Fluorouracil—colon cancer	0.000479	0.00173	CcSEcCtD
Fosphenytoin—Paraesthesia—Fluorouracil—colon cancer	0.000476	0.00172	CcSEcCtD
Fosphenytoin—Constipation—Irinotecan—colon cancer	0.000473	0.00171	CcSEcCtD
Fosphenytoin—Dyspnoea—Fluorouracil—colon cancer	0.000472	0.0017	CcSEcCtD
Fosphenytoin—Somnolence—Fluorouracil—colon cancer	0.000471	0.0017	CcSEcCtD
Fosphenytoin—Chills—Capecitabine—colon cancer	0.000468	0.00169	CcSEcCtD
Fosphenytoin—Dyspepsia—Fluorouracil—colon cancer	0.000466	0.00168	CcSEcCtD
Fosphenytoin—Decreased appetite—Fluorouracil—colon cancer	0.00046	0.00166	CcSEcCtD
Fosphenytoin—Feeling abnormal—Irinotecan—colon cancer	0.000456	0.00164	CcSEcCtD
Fosphenytoin—Dysuria—Methotrexate—colon cancer	0.000453	0.00164	CcSEcCtD
Fosphenytoin—Body temperature increased—Vincristine—colon cancer	0.000449	0.00162	CcSEcCtD
Fosphenytoin—Flatulence—Capecitabine—colon cancer	0.000447	0.00161	CcSEcCtD
Fosphenytoin—Dysgeusia—Capecitabine—colon cancer	0.000444	0.0016	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Methotrexate—colon cancer	0.000442	0.0016	CcSEcCtD
Fosphenytoin—Back pain—Capecitabine—colon cancer	0.000439	0.00158	CcSEcCtD
Fosphenytoin—Body temperature increased—Irinotecan—colon cancer	0.000437	0.00158	CcSEcCtD
Fosphenytoin—Feeling abnormal—Fluorouracil—colon cancer	0.000437	0.00158	CcSEcCtD
Fosphenytoin—Muscle spasms—Capecitabine—colon cancer	0.000436	0.00157	CcSEcCtD
Fosphenytoin—Pneumonia—Methotrexate—colon cancer	0.000435	0.00157	CcSEcCtD
Fosphenytoin—Tremor—Capecitabine—colon cancer	0.000425	0.00153	CcSEcCtD
Fosphenytoin—Renal failure—Methotrexate—colon cancer	0.000425	0.00153	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Capecitabine—colon cancer	0.000421	0.00152	CcSEcCtD
Fosphenytoin—Urticaria—Fluorouracil—colon cancer	0.000421	0.00152	CcSEcCtD
Fosphenytoin—Conjunctivitis—Methotrexate—colon cancer	0.00042	0.00152	CcSEcCtD
Fosphenytoin—Anaemia—Capecitabine—colon cancer	0.000419	0.00151	CcSEcCtD
Fosphenytoin—Body temperature increased—Fluorouracil—colon cancer	0.000419	0.00151	CcSEcCtD
Fosphenytoin—Sweating—Methotrexate—colon cancer	0.000414	0.00149	CcSEcCtD
Fosphenytoin—Malaise—Capecitabine—colon cancer	0.000409	0.00148	CcSEcCtD
Fosphenytoin—Epistaxis—Methotrexate—colon cancer	0.000408	0.00147	CcSEcCtD
Fosphenytoin—Vertigo—Capecitabine—colon cancer	0.000408	0.00147	CcSEcCtD
Fosphenytoin—Asthenia—Vincristine—colon cancer	0.000407	0.00147	CcSEcCtD
Fosphenytoin—Syncope—Capecitabine—colon cancer	0.000407	0.00147	CcSEcCtD
Fosphenytoin—Leukopenia—Capecitabine—colon cancer	0.000406	0.00146	CcSEcCtD
Fosphenytoin—Palpitations—Capecitabine—colon cancer	0.000401	0.00145	CcSEcCtD
Fosphenytoin—Loss of consciousness—Capecitabine—colon cancer	0.000399	0.00144	CcSEcCtD
Fosphenytoin—Asthenia—Irinotecan—colon cancer	0.000397	0.00143	CcSEcCtD
Fosphenytoin—Cough—Capecitabine—colon cancer	0.000396	0.00143	CcSEcCtD
Fosphenytoin—Hypertension—Capecitabine—colon cancer	0.000392	0.00141	CcSEcCtD
Fosphenytoin—Diarrhoea—Vincristine—colon cancer	0.000389	0.0014	CcSEcCtD
Fosphenytoin—Arthralgia—Capecitabine—colon cancer	0.000386	0.00139	CcSEcCtD
Fosphenytoin—Myalgia—Capecitabine—colon cancer	0.000386	0.00139	CcSEcCtD
Fosphenytoin—Pharyngitis—Methotrexate—colon cancer	0.000385	0.00139	CcSEcCtD
Fosphenytoin—Discomfort—Capecitabine—colon cancer	0.000382	0.00138	CcSEcCtD
Fosphenytoin—Diarrhoea—Irinotecan—colon cancer	0.000378	0.00137	CcSEcCtD
Fosphenytoin—Dry mouth—Capecitabine—colon cancer	0.000378	0.00136	CcSEcCtD
Fosphenytoin—Dizziness—Vincristine—colon cancer	0.000376	0.00136	CcSEcCtD
Fosphenytoin—Pruritus—Fluorouracil—colon cancer	0.000375	0.00135	CcSEcCtD
Fosphenytoin—Confusional state—Capecitabine—colon cancer	0.000373	0.00135	CcSEcCtD
Fosphenytoin—Infection—Capecitabine—colon cancer	0.000368	0.00133	CcSEcCtD
Fosphenytoin—Dizziness—Irinotecan—colon cancer	0.000366	0.00132	CcSEcCtD
Fosphenytoin—Shock—Capecitabine—colon cancer	0.000364	0.00131	CcSEcCtD
Fosphenytoin—Diarrhoea—Fluorouracil—colon cancer	0.000362	0.00131	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Capecitabine—colon cancer	0.000362	0.00131	CcSEcCtD
Fosphenytoin—Tinnitus—Methotrexate—colon cancer	0.000362	0.0013	CcSEcCtD
Fosphenytoin—Tachycardia—Capecitabine—colon cancer	0.000361	0.0013	CcSEcCtD
Fosphenytoin—Vomiting—Vincristine—colon cancer	0.000361	0.0013	CcSEcCtD
Fosphenytoin—Rash—Vincristine—colon cancer	0.000358	0.00129	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Capecitabine—colon cancer	0.000358	0.00129	CcSEcCtD
Fosphenytoin—Dermatitis—Vincristine—colon cancer	0.000358	0.00129	CcSEcCtD
Fosphenytoin—Headache—Vincristine—colon cancer	0.000356	0.00128	CcSEcCtD
Fosphenytoin—Anorexia—Capecitabine—colon cancer	0.000353	0.00127	CcSEcCtD
Fosphenytoin—Vomiting—Irinotecan—colon cancer	0.000352	0.00127	CcSEcCtD
Fosphenytoin—Dizziness—Fluorouracil—colon cancer	0.00035	0.00126	CcSEcCtD
Fosphenytoin—Rash—Irinotecan—colon cancer	0.000349	0.00126	CcSEcCtD
Fosphenytoin—Dermatitis—Irinotecan—colon cancer	0.000348	0.00126	CcSEcCtD
Fosphenytoin—Chills—Methotrexate—colon cancer	0.000348	0.00126	CcSEcCtD
Fosphenytoin—Headache—Irinotecan—colon cancer	0.000346	0.00125	CcSEcCtD
Fosphenytoin—Hypotension—Capecitabine—colon cancer	0.000346	0.00125	CcSEcCtD
Fosphenytoin—Nausea—Vincristine—colon cancer	0.000337	0.00122	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000337	0.00122	CcSEcCtD
Fosphenytoin—Vomiting—Fluorouracil—colon cancer	0.000337	0.00122	CcSEcCtD
Fosphenytoin—Insomnia—Capecitabine—colon cancer	0.000335	0.00121	CcSEcCtD
Fosphenytoin—Rash—Fluorouracil—colon cancer	0.000334	0.00121	CcSEcCtD
Fosphenytoin—Dermatitis—Fluorouracil—colon cancer	0.000334	0.0012	CcSEcCtD
Fosphenytoin—Paraesthesia—Capecitabine—colon cancer	0.000332	0.0012	CcSEcCtD
Fosphenytoin—Headache—Fluorouracil—colon cancer	0.000332	0.0012	CcSEcCtD
Fosphenytoin—Dysgeusia—Methotrexate—colon cancer	0.000331	0.00119	CcSEcCtD
Fosphenytoin—Dyspnoea—Capecitabine—colon cancer	0.00033	0.00119	CcSEcCtD
Fosphenytoin—Nausea—Irinotecan—colon cancer	0.000329	0.00119	CcSEcCtD
Fosphenytoin—Back pain—Methotrexate—colon cancer	0.000327	0.00118	CcSEcCtD
Fosphenytoin—Dyspepsia—Capecitabine—colon cancer	0.000326	0.00118	CcSEcCtD
Fosphenytoin—Decreased appetite—Capecitabine—colon cancer	0.000322	0.00116	CcSEcCtD
Fosphenytoin—Constipation—Capecitabine—colon cancer	0.000317	0.00114	CcSEcCtD
Fosphenytoin—Nausea—Fluorouracil—colon cancer	0.000315	0.00114	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Methotrexate—colon cancer	0.000313	0.00113	CcSEcCtD
Fosphenytoin—Anaemia—Methotrexate—colon cancer	0.000312	0.00113	CcSEcCtD
Fosphenytoin—Feeling abnormal—Capecitabine—colon cancer	0.000305	0.0011	CcSEcCtD
Fosphenytoin—Malaise—Methotrexate—colon cancer	0.000304	0.0011	CcSEcCtD
Fosphenytoin—Vertigo—Methotrexate—colon cancer	0.000303	0.00109	CcSEcCtD
Fosphenytoin—Leukopenia—Methotrexate—colon cancer	0.000302	0.00109	CcSEcCtD
Fosphenytoin—Cough—Methotrexate—colon cancer	0.000295	0.00106	CcSEcCtD
Fosphenytoin—Urticaria—Capecitabine—colon cancer	0.000294	0.00106	CcSEcCtD
Fosphenytoin—Body temperature increased—Capecitabine—colon cancer	0.000293	0.00106	CcSEcCtD
Fosphenytoin—Convulsion—Methotrexate—colon cancer	0.000293	0.00106	CcSEcCtD
Fosphenytoin—Arthralgia—Methotrexate—colon cancer	0.000287	0.00104	CcSEcCtD
Fosphenytoin—Myalgia—Methotrexate—colon cancer	0.000287	0.00104	CcSEcCtD
Fosphenytoin—Discomfort—Methotrexate—colon cancer	0.000284	0.00102	CcSEcCtD
Fosphenytoin—Confusional state—Methotrexate—colon cancer	0.000278	0.001	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Methotrexate—colon cancer	0.000276	0.000994	CcSEcCtD
Fosphenytoin—Infection—Methotrexate—colon cancer	0.000274	0.000988	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Methotrexate—colon cancer	0.00027	0.000974	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Methotrexate—colon cancer	0.000266	0.000961	CcSEcCtD
Fosphenytoin—Asthenia—Capecitabine—colon cancer	0.000266	0.000958	CcSEcCtD
Fosphenytoin—Anorexia—Methotrexate—colon cancer	0.000263	0.000948	CcSEcCtD
Fosphenytoin—Pruritus—Capecitabine—colon cancer	0.000262	0.000945	CcSEcCtD
Fosphenytoin—Hypotension—Methotrexate—colon cancer	0.000257	0.000929	CcSEcCtD
Fosphenytoin—Diarrhoea—Capecitabine—colon cancer	0.000253	0.000914	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000251	0.000906	CcSEcCtD
Fosphenytoin—Insomnia—Methotrexate—colon cancer	0.000249	0.000899	CcSEcCtD
Fosphenytoin—Paraesthesia—Methotrexate—colon cancer	0.000247	0.000893	CcSEcCtD
Fosphenytoin—Dyspnoea—Methotrexate—colon cancer	0.000246	0.000886	CcSEcCtD
Fosphenytoin—Somnolence—Methotrexate—colon cancer	0.000245	0.000884	CcSEcCtD
Fosphenytoin—Dizziness—Capecitabine—colon cancer	0.000245	0.000883	CcSEcCtD
Fosphenytoin—Dyspepsia—Methotrexate—colon cancer	0.000243	0.000875	CcSEcCtD
Fosphenytoin—Decreased appetite—Methotrexate—colon cancer	0.00024	0.000864	CcSEcCtD
Fosphenytoin—Vomiting—Capecitabine—colon cancer	0.000235	0.000849	CcSEcCtD
Fosphenytoin—Rash—Capecitabine—colon cancer	0.000233	0.000842	CcSEcCtD
Fosphenytoin—Dermatitis—Capecitabine—colon cancer	0.000233	0.000841	CcSEcCtD
Fosphenytoin—Headache—Capecitabine—colon cancer	0.000232	0.000837	CcSEcCtD
Fosphenytoin—Feeling abnormal—Methotrexate—colon cancer	0.000227	0.000819	CcSEcCtD
Fosphenytoin—Nausea—Capecitabine—colon cancer	0.00022	0.000793	CcSEcCtD
Fosphenytoin—Urticaria—Methotrexate—colon cancer	0.000219	0.00079	CcSEcCtD
Fosphenytoin—Body temperature increased—Methotrexate—colon cancer	0.000218	0.000786	CcSEcCtD
Fosphenytoin—Asthenia—Methotrexate—colon cancer	0.000198	0.000713	CcSEcCtD
Fosphenytoin—Pruritus—Methotrexate—colon cancer	0.000195	0.000703	CcSEcCtD
Fosphenytoin—Diarrhoea—Methotrexate—colon cancer	0.000189	0.00068	CcSEcCtD
Fosphenytoin—Dizziness—Methotrexate—colon cancer	0.000182	0.000658	CcSEcCtD
Fosphenytoin—Vomiting—Methotrexate—colon cancer	0.000175	0.000632	CcSEcCtD
Fosphenytoin—Rash—Methotrexate—colon cancer	0.000174	0.000627	CcSEcCtD
Fosphenytoin—Dermatitis—Methotrexate—colon cancer	0.000174	0.000626	CcSEcCtD
Fosphenytoin—Headache—Methotrexate—colon cancer	0.000173	0.000623	CcSEcCtD
Fosphenytoin—Nausea—Methotrexate—colon cancer	0.000164	0.000591	CcSEcCtD
Fosphenytoin—Phenylbutazone—PTGS2—colon cancer	1.76e-05	0.629	CrCbGaD
Fosphenytoin—Phenytoin—ABCB1—colon cancer	1.04e-05	0.371	CrCbGaD
